CSA Medical, Inc., a leader in developing spray cryotherapy solutions for the treatment of airway diseases, today announced data correlating the positive clinical outcomes following Metered CryoSpray (MCS), using the RejuvenAir(r) System, with evidence of airway tissue remodeling in chronic bronchitis subjects.
